In human SLE, we found that DCs with lower Dbc1 mRNA level showed low level of HLA‐DQA1, CD1C, and FCR1A, suggesting low expression of DBC1 presented a mild antigen‐presenting ability and leading to a tolerogenic phenotype. This evidence concerns the gene HLA-DQA1 and systemic lupus erythematosus.